- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05650853
Exploration of eJaculatory Anatomy Concept Study (EJAC Study)
Study of the Biomechanical Anatomy of Ejaculation
Ejaculatory dysfunctions (ED) are an important cause of postoperative dissatisfaction, which lead to a decrease in the intensity of orgasms in 50% of patients. ED is a cause for concern for almost a third of patients who need surgery. Surgical techniques have been developed to limit the occurrence of postoperative ED, but their results remain heterogeneous.
There are very few studies on the biomechanical anatomy of ejaculation. Ejaculation is a complex phenomenon involving different structures and in particular the Veru Montanum. This is the key element in the emission of ejaculate within the prostatic urethra. In addition, there is a structure located in the resection zone of the prostate adenoma. It has therefore been suggested that its resection was a primary source of ED.
A single observational study carried out in by Gil Vernet et al in 1994 evaluated on a single healthy 18-year-old volunteer the ejaculatory mechanism of expulsion using an endorectal probe recording the movements of the prostate, the bladder neck and of the proximal urethra during ejaculation.
A contemporary study of the biomechanics of the ejaculatory expulsion phase could confirm and improve understanding of the involvement of anatomical structures. The results of our study aim to adapt surgical techniques aimed at limiting the risk of postoperative ED.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Vincent Misraï, MD
- Phone Number: +33 5 62 21 33 26
- Email: vmisrai@clinique-pasteur.com
Study Locations
-
-
-
Toulouse, France
- Clinique PASTEUR
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Affiliated subject or beneficiary of a social security scheme
- Subject agreeing to participate and having signed the free, informed consent.
Exclusion Criteria:
- Subject with ejaculatory dysfunction
- Subject with urinary dysfunction
- History of urinary or penile surgery
- Subject with untreated urinary tract infection
- History of chronic prostatitis
- Pathology making it impossible to introduce the endorectal probe or the ureteroscope
- History of colorectal inflammatory disease
- Recent intake (within 30 days) of drugs known to interfere with ejaculation
- History of intolerance or allergy to any of the drugs used in the study
- Subject participating in another clinical study
- Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; Hospitalized without consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study intervention
Transrectal ultrasound and Urethroscopy
|
Examinations for observation of the pre, per and post-ejaculatory phases
Examinations for observation of the pre, per and post-ejaculatory phases
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peri-urethral muscle contraction
Time Frame: At Day 0
|
Qualitative description of peri-urethral muscle contraction according to ultrasound videos analysis
|
At Day 0
|
Urethra, bladder neck and prostate movements
Time Frame: At Day 0
|
Qualitative description of movements of the urethra, bladder neck and prostate according to ultrasound videos analysis
|
At Day 0
|
Sperm flow within the prostatic urethra
Time Frame: At Day 0
|
Qualitative description of sperm flow within the prostatic urethra according to ultrasound videos analysis
|
At Day 0
|
Spermatic fluid via the ejaculatory ducts
Time Frame: At Day 6
|
Qualitative description of the expulsion and flow of spermatic fluid via the ejaculatory ducts according to urethroscopy videos analysis
|
At Day 6
|
Veru montanum mobility and urethral contraction.
Time Frame: At Day 6
|
Qualitative description of veru montanum mobility and urethral contraction according to urethroscopy videos analysis
|
At Day 6
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Benjamin Pradère, MD, Clinique La Croix du Sud
- Study Director: Eric Bruguière, MD, Clinique PASTEUR
- Study Director: Vincent Misraï, MD, Clinique PASTEUR
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2022-A01594-39
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ejaculatory Dysfunction
-
Sohag UniversityNot yet recruitingBPH | Ejaculatory Dysfunction
-
Dong-A Pharmaceutical Co., Ltd.CompletedPremature Ejaculatory DysfunctionKorea, Republic of
-
William Beaumont HospitalsRecruitingMale Sexual Dysfunction | Ejaculatory DysfunctionUnited States
-
Stanford UniversityCompleted
-
Istanbul Medipol University HospitalAnkara Education and Research Hospital; Ataturk University; Yuzuncu Yıl University and other collaboratorsRecruitingQuality of Life | Lower Urinary Tract Symptoms | Sexual Dysfunction | Erectile Dysfunction | Incontinence | Ejaculatory DysfunctionTurkey
-
Stanford UniversityRecruitingSexual Dysfunction | Erectile Dysfunction | Delayed Ejaculation | AnorgasmiaUnited States
-
Eli Lilly and CompanyCompletedHypogonadism | Ejaculatory DysfunctionUnited States, Canada
-
Mansoura UniversityUnknownProstate Hyperplasia | Transurethral Incision Of The Prostate | Ejaculatory DysfunctionEgypt
-
Boston Medical GroupCompleted
-
Clinica ARS MedicaUnknown
Clinical Trials on Transrectal ultrasound
-
Assiut UniversityNot yet recruitingInfertility Due to Azoospermia
-
Kafrelsheikh UniversityUnknownBenign Prostatic HyperplasiaEgypt
-
British Columbia Cancer AgencyCompleted
-
Johns Hopkins UniversityCompletedBenign Prostatic HyperplasiaUnited States
-
Duke UniversityEigenRecruitingUterine CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedProstate CancerUnited States
-
Turku University HospitalCompletedProstate CancerFinland
-
University of FlorenceUnknown
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendedProstate Cancer | Prostate NeoplasmUnited Kingdom